ÅǸ޴º
- ·ù¸¶Æ¼½ºÅ¬¸®´Ð, °¨¿°¼ºÁúȯ, ÇØ¿Ü¿©ÇàŬ¸®´Ð(¿¹¹æÁ¢Á¾)
ÇÐÀ§ ¹× °æ·Â
¿µ³²´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¿µ³²´ëÇб³ ´ëÇпø ¼®»ç, ¹Ú»ç
¿µ³²´ëÇб³º´¿ø ÀÎÅÏ, ·¹Áö´øÆ® ¼ö·Ã
¿µ³²´ëÇб³º´¿ø ÀüÀÓÀÇ
·ù¸¶Æ¼½º ºÐ°úÀü¹®ÀÇ
úÞ Â÷ÀǰúÇдëÇб³ ºÎ¼Ó ±¸¹ÌÂ÷º´¿ø ·ù¸¶Æ¼½º°¨¿°³»°ú °úÀå, °¨¿°°ü¸®½ÇÀå
±¹³»¿Ü ¿¬¼ö ¹× ¼ö»ó°æ·Â
¹Ì±¹ ÀÇ»ç ÀÚ°ÝÁõ (ECFMG) Ãëµæ
UCSD school of medicine, VA Hospital ¿¬¼ö
³í¹®
- A case of Minimal change disease with mycophenolate mofetil in a patient with SLE (Korean Journal of Internal Medicine, 2011)
- ¾Æ±Þ¼º °ñ¼öÁ¾°ú ±Þ¼º ÀçȰ¼º ¸¸¼ºBÇü °£¿°¿¡¼ ¹ß»ýÇÑ IÇü Àú¿Â ±Û·ÎºÒ¸°Ç÷Áõ 1¿¹ (´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö, 2011)
- ¼ºÀÎÇü ½ºÆ¿º´À¸·Î ¿ÀÀÎµÈ Àü½Å È«¹Ý ·çǪ½º 1¿¹ (¿µ³²ÀÇ´ëÇмúÁö, 2010)
- »ó¾Ç°ñ ħ¹üÀ¸·Î ³ªÅ¸³ °ÅÁþ ¸²ÇÁÁ¾¾ç IgG4 ¿¬°üº´Áõ 1¿¹ (¿µ³²ÀÇ´ëÇмúÁö, 2013)
- ´Ù±â°üºÎÀü, ºó¾ÈÀåÁõÈıº, Àç»ýºÒ·®¼º ºóÇ÷·Î ÇÕº´µÈ Á¦2Çü ´ÙºÐºñ¼± ÀÚ°¡¸é¿ªÁõÈıº 1¿¹ (´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö, 2015)
- ·ù¸¶Æ¼½º °üÀý¿° ȯÀÚ¿¡¼ Methotrexate Ä¡·á°¡ °æµ¿¸Æ ³»Á߸· µÎ²²¿¡ ¹ÌÄ¡´Â ¿µÇâ (¼®»çÇÐÀ§³í¹®, 2011)
- Polyglandular Autoimmune Syndrome Type 2 Complicated by Multiple Organ Failure, Empty Sella Syndrome and Aplastic Anemia (Journal of Rheumatic Diseases, 2015)
- Age-related NADPH Oxidase (arNOX) Activity Correlated with Cartilage Degradation and Bony Changes in Age-related Osteoarthritis (J Korean Med Sci 2015; 30: 1246-1252)
- Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis
(J Korean Med Sci 2015; 30: 1589-1596)
- ·çǪ½º ½Å¿°¿¡¼ Ç×-ȲÈÇìÆÄ¶õ Ç×üÀÇ »ý¼º°ú »ç±¸Ã¼ ±âÀú¸· ȲÈÇìÆÄ¶õÇÁ·ÎÅ׿À±Û¸®ÄÀÇ ±â´ÉÀû ¼Ò½Ç (¹Ú»çÇÐÀ§³í¹®, 2016)
¿µ³²´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¿µ³²´ëÇб³ ´ëÇпø ¼®»ç, ¹Ú»ç
¿µ³²´ëÇб³º´¿ø ÀÎÅÏ, ·¹Áö´øÆ® ¼ö·Ã
¿µ³²´ëÇб³º´¿ø ÀüÀÓÀÇ
·ù¸¶Æ¼½º ºÐ°úÀü¹®ÀÇ
úÞ Â÷ÀǰúÇдëÇб³ ºÎ¼Ó ±¸¹ÌÂ÷º´¿ø ·ù¸¶Æ¼½º°¨¿°³»°ú °úÀå, °¨¿°°ü¸®½ÇÀå
±¹³»¿Ü ¿¬¼ö ¹× ¼ö»ó°æ·Â
¹Ì±¹ ÀÇ»ç ÀÚ°ÝÁõ (ECFMG) Ãëµæ
UCSD school of medicine, VA Hospital ¿¬¼ö
³í¹®
- A case of Minimal change disease with mycophenolate mofetil in a patient with SLE (Korean Journal of Internal Medicine, 2011)
- ¾Æ±Þ¼º °ñ¼öÁ¾°ú ±Þ¼º ÀçȰ¼º ¸¸¼ºBÇü °£¿°¿¡¼ ¹ß»ýÇÑ IÇü Àú¿Â ±Û·ÎºÒ¸°Ç÷Áõ 1¿¹ (´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö, 2011)
- ¼ºÀÎÇü ½ºÆ¿º´À¸·Î ¿ÀÀÎµÈ Àü½Å È«¹Ý ·çǪ½º 1¿¹ (¿µ³²ÀÇ´ëÇмúÁö, 2010)
- »ó¾Ç°ñ ħ¹üÀ¸·Î ³ªÅ¸³ °ÅÁþ ¸²ÇÁÁ¾¾ç IgG4 ¿¬°üº´Áõ 1¿¹ (¿µ³²ÀÇ´ëÇмúÁö, 2013)
- ´Ù±â°üºÎÀü, ºó¾ÈÀåÁõÈıº, Àç»ýºÒ·®¼º ºóÇ÷·Î ÇÕº´µÈ Á¦2Çü ´ÙºÐºñ¼± ÀÚ°¡¸é¿ªÁõÈıº 1¿¹ (´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö, 2015)
- ·ù¸¶Æ¼½º °üÀý¿° ȯÀÚ¿¡¼ Methotrexate Ä¡·á°¡ °æµ¿¸Æ ³»Á߸· µÎ²²¿¡ ¹ÌÄ¡´Â ¿µÇâ (¼®»çÇÐÀ§³í¹®, 2011)
- Polyglandular Autoimmune Syndrome Type 2 Complicated by Multiple Organ Failure, Empty Sella Syndrome and Aplastic Anemia (Journal of Rheumatic Diseases, 2015)
- Age-related NADPH Oxidase (arNOX) Activity Correlated with Cartilage Degradation and Bony Changes in Age-related Osteoarthritis (J Korean Med Sci 2015; 30: 1246-1252)
- Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis
(J Korean Med Sci 2015; 30: 1589-1596)
- ·çǪ½º ½Å¿°¿¡¼ Ç×-ȲÈÇìÆÄ¶õ Ç×üÀÇ »ý¼º°ú »ç±¸Ã¼ ±âÀú¸· ȲÈÇìÆÄ¶õÇÁ·ÎÅ׿À±Û¸®ÄÀÇ ±â´ÉÀû ¼Ò½Ç (¹Ú»çÇÐÀ§³í¹®, 2016)
Copyright ¨Ï chamc, All rights reserved.